What is the Aurobindo Pharma Ltd share price today?

The share price of NSE:AUROPHARMA-EQ on 07 Sep 2026 (as of 10:58:52 IST) is ₹1655.60.

What is the NSE:AUROPHARMA-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:AUROPHARMA-EQ 52 week high low range shows a high of ₹1717.00 and a low of ₹1035.40.

What is the Aurobindo Pharma Ltd market cap?

As on 07 Sep 2026, Aurobindo Pharma Ltd market cap is ₹95127.20 Cr.

What is the shareholding pattern of Aurobindo Pharma Ltd Stock?

The shareholding pattern of Aurobindo Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 51.88% Foreign Institutional Investors (FII): 16.38% Domestic Institutional Investors (DII): 8.34% Mutual Funds: 16.71% Retail & Others: 6.69% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Aurobindo Pharma Ltd?

The Price-to-Earnings (PE) ratio of Aurobindo Pharma Ltd is 25.62, and the Price-to-Book (PB) ratio is 2.00, as on 07 Sep 2026.

Aurobindo Pharma Share Price

1716.00-5.50 (-0.32%)

+54.61% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.32%

1 Week

-1.04%

1 Month

+6.07%

3 Month

+10.34%

6 Month

+30.57%

YTD

+45.05%

1 Year

+54.61%

5 Year

+133.96%

10 Year

+104.01%

Max

+188471.43%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1710.00

1689.30

1605.70

1512.00

1266.10

1066.80

High

1740.00

About

Aurobindo Pharma is one of the leading vertically integrated formulations & API manufacturing companies in the world. It has a strong R&D focus and has a multi-product portfolio with manufacturing Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

Aurobindo Pharma Share Price

1716.00-5.50 (-0.32%)

+54.61% past 1 Year

Financial overview

Compounded Sales Growth

10 years9%

5 years6%

3 years11%

Last year6%

Compounded Profit Growth

10 years6%

5 years-8%

3 years22%

Last year1%

Stock Price CAGR

10 years7%

5 years19%

3 years26%

1 year55%

Return on Equity

10 years17%

5 years10%

3 years11%

Last year10%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
9%	6%	11%	6%
6%	-8%	22%	1%
7%	19%	26%	55%
17%	10%	11%	10%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,865	₹442437 Cr	36.58	12.07	62.82	₹11479 Cr
9,624	₹248054 Cr	84.8	34.04	128.41	₹2568 Cr
4,985	₹189842 Cr	87.04	16.72	97.06	₹2163 Cr
1,170.1	₹115810 Cr	25.66	9.42	62.53	₹5040 Cr
1,383	₹111565 Cr	33.1	9.77	57.87	₹3879 Cr
2,034	₹108338 Cr	99.09	6.8	29.25	₹889 Cr
2,465	₹102410 Cr	50.14	13.75	71.08	₹1913 Cr
1,211.2	₹101163 Cr	31.4	5.32	63.99	₹4196 Cr
1,721.5	₹97642 Cr	26.3	17.95	96.84	₹3505 Cr
2,102.8	₹96950 Cr	17.54	30.95	154.35	₹5333 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹58 Cr	₹58 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹29 Cr	₹29 Cr	₹29 Cr	₹29 Cr	₹29 Cr	₹28 Cr	₹27 Cr	₹27 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹6 L	₹7 L	₹10 L	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹37833 Cr	₹32595 Cr	₹29784 Cr	₹26781 Cr	₹24517 Cr	₹21871 Cr	₹16766 Cr	₹13832 Cr	₹11622 Cr	₹9313 Cr	₹7228 Cr	₹5127 Cr	₹3721 Cr	₹2577 Cr	₹2311 Cr	₹2416 Cr	₹1801 Cr	₹1214 Cr	₹1097 Cr
₹37833 Cr	₹32595 Cr	₹29784 Cr	₹26781 Cr	₹24517 Cr	₹21871 Cr	₹16766 Cr	₹13832 Cr	₹11622 Cr	₹9313 Cr	₹7228 Cr	₹5127 Cr	₹3721 Cr	₹2577 Cr	₹2311 Cr	₹2416 Cr	₹1801 Cr	₹1214 Cr	₹1097 Cr
₹37891 Cr	₹32653 Cr	₹29843 Cr	₹26840 Cr	₹24576 Cr	₹21930 Cr	₹16825 Cr	₹13891 Cr	₹11680 Cr	₹9372 Cr	₹7287 Cr	₹5156 Cr	₹3750 Cr	₹2606 Cr	₹2340 Cr	₹2445 Cr	₹1829 Cr	₹1241 Cr	₹1124 Cr
-₹8 Cr	-₹6 Cr	₹8 Cr	₹12 Cr	-₹2 Cr	-₹88 L	₹14 L	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹26 Cr	₹26 Cr	₹11 Cr	₹10 Cr	₹9 Cr	₹4 Cr	₹3 Cr	₹3 Cr
₹798 Cr	₹1159 Cr	₹2135 Cr	₹619 Cr	₹249 Cr	₹168 Cr	₹0	₹49 Cr	₹27 Cr	₹178 Cr	₹380 Cr	₹774 Cr	₹1101 Cr	₹1084 Cr	₹862 Cr	₹450 Cr	₹864 Cr	₹988 Cr	₹633 Cr
₹5 Cr	₹402 Cr	₹0	₹0	₹0	₹0	₹0	₹131 Cr	₹424 Cr	₹4 Cr	₹363 Cr	₹588 Cr	₹178 Cr	₹64 Cr	₹103 Cr	₹74 Cr	₹1291 Cr	₹1345 Cr	₹1214 Cr
-₹1178 Cr	-₹990 Cr	-₹856 Cr	-₹288 Cr	₹122 Cr	₹122 Cr	₹128 Cr	₹98 Cr	₹76 Cr	-₹118 Cr	-₹182 Cr	₹206 Cr	₹205 Cr	₹68 Cr	-₹2 Cr	₹119 Cr	₹91 Cr	₹77 Cr	₹73 Cr
₹1071 Cr	₹308 Cr	₹304 Cr	₹363 Cr	₹360 Cr	₹360 Cr	₹352 Cr	₹34 Cr	₹11 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹400 Cr	₹283 Cr	₹226 Cr	₹173 Cr	₹172 Cr	₹157 Cr	₹75 Cr	₹47 Cr	₹56 Cr	₹39 Cr	₹23 Cr	₹24 Cr	₹9 Cr	₹9 Cr	₹4 Cr	₹3 Cr	₹0	₹0	₹0
₹1097 Cr	₹1163 Cr	₹1809 Cr	₹867 Cr	₹903 Cr	₹807 Cr	₹555 Cr	₹358 Cr	₹594 Cr	₹102 Cr	₹584 Cr	₹1592 Cr	₹1494 Cr	₹1225 Cr	₹967 Cr	₹645 Cr	₹2246 Cr	₹2410 Cr	₹1920 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹5567 Cr	₹4189 Cr	₹4454 Cr	₹3871 Cr	₹2703 Cr	₹2795 Cr	₹2576 Cr	₹2552 Cr	₹2373 Cr	₹2155 Cr	₹2457 Cr	₹2051 Cr	₹1351 Cr	₹964 Cr	₹660 Cr	₹776 Cr	₹604 Cr	₹515 Cr	₹463 Cr
₹5828 Cr	₹4463 Cr	₹3161 Cr	₹2980 Cr	₹3107 Cr	₹2684 Cr	₹2875 Cr	₹2511 Cr	₹1967 Cr	₹1287 Cr	₹1578 Cr	₹1365 Cr	₹388 Cr	₹151 Cr	₹580 Cr	₹699 Cr	₹68 Cr	₹29 Cr	₹91 Cr
₹6080 Cr	₹5470 Cr	₹4078 Cr	₹4230 Cr	₹2118 Cr	₹4804 Cr	₹5422 Cr	₹6573 Cr	₹4031 Cr	₹2903 Cr	₹3673 Cr	₹2502 Cr	₹2355 Cr	₹2236 Cr	₹1608 Cr	₹1235 Cr	₹0	₹0	₹0
₹564 Cr	₹560 Cr	₹506 Cr	₹412 Cr	₹229 Cr	₹382 Cr	₹512 Cr	₹385 Cr	₹294 Cr	₹261 Cr	₹133 Cr	₹218 Cr	₹127 Cr	₹80 Cr	₹66 Cr	₹58 Cr	₹35 Cr	₹27 Cr	₹32 Cr
₹18039 Cr	₹14682 Cr	₹12199 Cr	₹11494 Cr	₹8156 Cr	₹10665 Cr	₹11385 Cr	₹12021 Cr	₹8666 Cr	₹6606 Cr	₹7840 Cr	₹6136 Cr	₹4220 Cr	₹3431 Cr	₹2915 Cr	₹2768 Cr	₹708 Cr	₹570 Cr	₹587 Cr
₹57019 Cr	₹48492 Cr	₹43859 Cr	₹39213 Cr	₹33633 Cr	₹33401 Cr	₹28765 Cr	₹26271 Cr	₹20942 Cr	₹16082 Cr	₹15714 Cr	₹12910 Cr	₹9490 Cr	₹7273 Cr	₹6232 Cr	₹5868 Cr	₹4787 Cr	₹4224 Cr	₹3634 Cr
₹1358 Cr	₹1290 Cr	₹311 Cr	₹159 Cr	₹158 Cr	₹141 Cr	₹146 Cr	₹134 Cr	₹212 Cr	₹197 Cr	₹177 Cr	₹195 Cr	₹151 Cr	₹180 Cr	₹67 Cr	₹55 Cr	₹58 Cr	₹59 Cr	₹421 Cr
₹7676 Cr	₹7942 Cr	₹6315 Cr	₹4862 Cr	₹2373 Cr	₹4972 Cr	₹5562 Cr	₹6967 Cr	₹4770 Cr	₹3364 Cr	₹5041 Cr	₹4451 Cr	₹3769 Cr	₹3435 Cr	₹3096 Cr	₹2414 Cr	₹2155 Cr	₹2333 Cr	₹1847 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹29251 Cr	₹24463 Cr	₹23448 Cr	₹18593 Cr	₹15943 Cr	₹13613 Cr	₹12441 Cr	₹10498 Cr	₹7895 Cr	₹5635 Cr	₹4570 Cr	₹5446 Cr	₹4183 Cr	₹3763 Cr	₹3086 Cr	₹2438 Cr	₹2408 Cr	₹1974 Cr	₹1718 Cr
₹11845 Cr	₹9669 Cr	₹8952 Cr	₹7570 Cr	₹5411 Cr	₹4240 Cr	₹3045 Cr	₹2023 Cr	₹1374 Cr	₹802 Cr	₹390 Cr	₹1740 Cr	₹1461 Cr	₹1125 Cr	₹892 Cr	₹699 Cr	₹697 Cr	₹575 Cr	₹418 Cr
₹0	₹0	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹17407 Cr	₹14794 Cr	₹14493 Cr	₹11024 Cr	₹10532 Cr	₹9374 Cr	₹9396 Cr	₹8475 Cr	₹6521 Cr	₹4834 Cr	₹4180 Cr	₹3706 Cr	₹2722 Cr	₹2639 Cr	₹2195 Cr	₹1739 Cr	₹1711 Cr	₹1399 Cr	₹1300 Cr
₹3009 Cr	₹3266 Cr	₹2739 Cr	₹4496 Cr	₹2938 Cr	₹2429 Cr	₹1622 Cr	₹1342 Cr	₹1400 Cr	₹1237 Cr	₹836 Cr	₹355 Cr	₹242 Cr	₹149 Cr	₹470 Cr	₹528 Cr	₹570 Cr	₹536 Cr	₹215 Cr
₹304 Cr	₹252 Cr	₹322 Cr	₹392 Cr	₹618 Cr	₹431 Cr	₹555 Cr	₹360 Cr	₹312 Cr	₹246 Cr	₹123 Cr	₹14 L	₹20 Cr	₹22 Cr	₹20 Cr	₹38 Cr	-₹46 L	-₹46 L	-₹45 L
₹304 Cr	₹252 Cr	₹322 Cr	₹392 Cr	₹618 Cr	₹431 Cr	₹555 Cr	₹360 Cr	₹312 Cr	₹246 Cr	₹123 Cr	₹14 L	₹20 Cr	₹22 Cr	₹20 Cr	₹38 Cr	-₹46 L	-₹46 L	-₹45 L
₹972 Cr	₹973 Cr	₹715 Cr	₹794 Cr	₹575 Cr	₹658 Cr	₹378 Cr	₹397 Cr	₹262 Cr	₹256 Cr	₹237 Cr	₹455 Cr	₹789 Cr	₹238 Cr	₹108 Cr	₹111 Cr	₹0	₹0	₹0
₹414 Cr	₹410 Cr	₹256 Cr	₹67 Cr	₹38 Cr	₹53 Cr	₹37 Cr	₹39 Cr	₹87 Cr	₹81 Cr	₹32 Cr	₹30 Cr	₹18 Cr	₹19 Cr	₹12 L	₹1 Cr	₹0	₹0	₹0
₹24310 Cr	₹21330 Cr	₹19653 Cr	₹17667 Cr	₹15510 Cr	₹13578 Cr	₹12352 Cr	₹10939 Cr	₹8764 Cr	₹6875 Cr	₹5420 Cr	₹4611 Cr	₹3859 Cr	₹3136 Cr	₹2968 Cr	₹2547 Cr	₹2280 Cr	₹1935 Cr	₹1514 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹747 Cr	₹1 L	₹51 Cr	₹151 Cr	₹379 Cr	₹160 Cr	₹2 L	₹2 L	₹2 L	₹2 L	₹2 L	₹20 Cr	₹3 L	₹4 L	₹19 Cr	₹4 L	₹74 L	₹72 L	₹61 Cr
₹12053 Cr	₹10544 Cr	₹9808 Cr	₹8511 Cr	₹7554 Cr	₹9027 Cr	₹7700 Cr	₹7246 Cr	₹5858 Cr	₹4331 Cr	₹4056 Cr	₹3611 Cr	₹2368 Cr	₹1924 Cr	₹1546 Cr	₹1455 Cr	₹1102 Cr	₹878 Cr	₹795 Cr
₹7094 Cr	₹5746 Cr	₹4817 Cr	₹4466 Cr	₹4012 Cr	₹3503 Cr	₹4315 Cr	₹3414 Cr	₹3080 Cr	₹2765 Cr	₹4607 Cr	₹3539 Cr	₹2637 Cr	₹1597 Cr	₹1240 Cr	₹1231 Cr	₹956 Cr	₹890 Cr	₹665 Cr
₹9870 Cr	₹8235 Cr	₹6278 Cr	₹6084 Cr	₹4190 Cr	₹5474 Cr	₹2842 Cr	₹1957 Cr	₹1262 Cr	₹513 Cr	₹800 Cr	₹469 Cr	₹179 Cr	₹208 Cr	₹71 Cr	₹187 Cr	₹73 Cr	₹128 Cr	₹283 Cr
₹399 Cr	₹654 Cr	₹519 Cr	₹555 Cr	₹394 Cr	₹518 Cr	₹489 Cr	₹1920 Cr	₹1223 Cr	₹1085 Cr	₹464 Cr	₹272 Cr	₹211 Cr	₹200 Cr	₹172 Cr	₹89 Cr	₹94 Cr	₹61 Cr	₹53 Cr
₹2545 Cr	₹1983 Cr	₹2299 Cr	₹1692 Cr	₹1515 Cr	₹1058 Cr	₹1066 Cr	₹796 Cr	₹754 Cr	₹512 Cr	₹367 Cr	₹388 Cr	₹237 Cr	₹208 Cr	₹217 Cr	₹359 Cr	₹281 Cr	₹333 Cr	₹264 Cr
₹32709 Cr	₹27163 Cr	₹23772 Cr	₹21460 Cr	₹18044 Cr	₹19740 Cr	₹16413 Cr	₹15332 Cr	₹12178 Cr	₹9206 Cr	₹10294 Cr	₹8299 Cr	₹5631 Cr	₹4137 Cr	₹3264 Cr	₹3321 Cr	₹2507 Cr	₹2290 Cr	₹2120 Cr
₹14670 Cr	₹12480 Cr	₹11573 Cr	₹9966 Cr	₹9888 Cr	₹9075 Cr	₹5028 Cr	₹3312 Cr	₹3512 Cr	₹2601 Cr	₹2454 Cr	₹2162 Cr	₹1411 Cr	₹706 Cr	₹349 Cr	₹553 Cr	₹1799 Cr	₹1720 Cr	₹1533 Cr
₹57019 Cr	₹48492 Cr	₹43859 Cr	₹39213 Cr	₹33633 Cr	₹33401 Cr	₹28765 Cr	₹26271 Cr	₹20942 Cr	₹16082 Cr	₹15714 Cr	₹12910 Cr	₹9490 Cr	₹7273 Cr	₹6232 Cr	₹5868 Cr	₹4787 Cr	₹4224 Cr	₹3634 Cr
₹652	₹562	₹509	₹458	₹419	₹374	₹287	₹237	₹199	₹160	₹125	₹177	₹129	₹89	₹80	₹84	₹328	₹231	₹209
₹652	₹562	₹509	₹458	₹419	₹374	₹287	₹237	₹199	₹160	₹125	₹88	₹64	₹45	₹40	₹42	₹33	₹23	₹21

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹5112 Cr	₹5066 Cr	₹4380 Cr	₹2613 Cr	₹3373 Cr	₹7344 Cr	₹3743 Cr	₹3091 Cr	₹3241 Cr	₹3061 Cr	₹2744 Cr	₹2168 Cr	₹1533 Cr	₹374 Cr	₹108 Cr	₹799 Cr	₹752 Cr	₹73 Cr	₹292 Cr
₹2083 Cr	₹1834 Cr	₹1496 Cr	₹1586 Cr	₹1344 Cr	-₹1663 Cr	₹1091 Cr	₹814 Cr	₹535 Cr	₹409 Cr	₹488 Cr	₹406 Cr	₹515 Cr	₹442 Cr	₹387 Cr	₹198 Cr	₹100 Cr	₹428 Cr	₹40 Cr
₹164 Cr	-₹1244 Cr	-₹1675 Cr	-₹1095 Cr	₹1558 Cr	-₹1067 Cr	₹308 Cr	-₹1485 Cr	-₹1123 Cr	₹583 Cr	-₹1079 Cr	-₹842 Cr	-₹1057 Cr	-₹422 Cr	-₹128 Cr	-₹469 Cr	-₹274 Cr	-₹334 Cr	-₹127 Cr
₹7358 Cr	₹5656 Cr	₹4201 Cr	₹3104 Cr	₹6275 Cr	₹4614 Cr	₹5142 Cr	₹2421 Cr	₹2653 Cr	₹4052 Cr	₹2152 Cr	₹1732 Cr	₹990 Cr	₹394 Cr	₹367 Cr	₹527 Cr	₹578 Cr	₹166 Cr	₹205 Cr
₹5526 Cr	₹3925 Cr	₹2435 Cr	₹2387 Cr	₹5016 Cr	₹3329 Cr	₹4381 Cr	₹1651 Cr	₹1955 Cr	₹3279 Cr	₹1420 Cr	₹1237 Cr	₹646 Cr	₹275 Cr	₹326 Cr	₹335 Cr	₹425 Cr	₹136 Cr	₹159 Cr
-₹3459 Cr	-₹1876 Cr	-₹4256 Cr	-₹3978 Cr	-₹3212 Cr	₹599 Cr	-₹1568 Cr	-₹2903 Cr	-₹1927 Cr	-₹1787 Cr	-₹1445 Cr	-₹1398 Cr	-₹819 Cr	-₹246 Cr	-₹563 Cr	-₹599 Cr	-₹399 Cr	-₹406 Cr	-₹75 Cr
-₹1269 Cr	₹120 Cr	₹800 Cr	₹1814 Cr	-₹2969 Cr	-₹1365 Cr	-₹1947 Cr	₹1919 Cr	₹864 Cr	-₹1915 Cr	₹365 Cr	₹93 Cr	₹118 Cr	₹108 Cr	₹119 Cr	₹407 Cr	-₹84 Cr	₹165 Cr	-₹218 Cr
₹799 Cr	₹2169 Cr	-₹1021 Cr	₹223 Cr	-₹1164 Cr	₹2563 Cr	₹866 Cr	₹667 Cr	₹892 Cr	-₹424 Cr	₹340 Cr	-₹68 Cr	-₹55 Cr	₹137 Cr	-₹118 Cr	₹143 Cr	-₹58 Cr	-₹105 Cr	-₹134 Cr
₹5564 Cr	₹3385 Cr	₹4392 Cr	₹4163 Cr	₹5330 Cr	₹2747 Cr	₹1876 Cr	₹1210 Cr	₹318 Cr	₹743 Cr	₹404 Cr	₹148 Cr	₹203 Cr	₹66 Cr	₹184 Cr	₹45 Cr	₹103 Cr	₹236 Cr	₹375 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹380 Cr	₹23 L	₹0	₹0	-₹4 Cr	₹76 L	₹0	₹0
₹18 L	₹66 L	₹0	₹6 Cr	-₹3 Cr	₹22 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹829 Cr	₹9 Cr	₹14 Cr	-₹6 L	₹20 L	-₹2 Cr	₹5 Cr	-₹2 Cr	-₹17 L	-₹14 L	-₹30 L	₹2 Cr	-₹12 L	₹47 L	-₹1 L	-₹8 L	₹2 Cr	-₹33 Cr	₹1 Cr
₹7191 Cr	₹5564 Cr	₹3385 Cr	₹4392 Cr	₹4163 Cr	₹5330 Cr	₹2747 Cr	₹1876 Cr	₹1210 Cr	₹320 Cr	₹744 Cr	₹461 Cr	₹148 Cr	₹203 Cr	₹66 Cr	₹184 Cr	₹47 Cr	₹97 Cr	₹242 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Aurobindo Pharma Share Price

1716.00-5.50 (-0.32%)

+54.61% past 1 Year

Shareholding summary

Promoters

51.88%

FII

16.38%

DII

8.34%

16.71%

Others

6.69%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
51.88%	51.82%	51.82%	51.82%	51.82%	51.82%
16.38%	15.24%	13.95%	14.21%	14.38%	15.33%
8.34%	8.03%	8.14%	8.30%	7.97%	8.02%
16.71%	17.79%	19.52%	19.30%	18.96%	18.21%
6.69%	7.12%	6.57%	6.37%	6.87%	6.62%

Bulk & block deals

Name

Goldman Sachs Bank Europese - Odi

Goldman Sachs (Singapore) Pte.- Odi

Societe Generale

Marshall Wace Investment Strategies - Eureka Fund

Marshall Wace Investment Strategies Eureka Fund

Marshall Wace Investment Strategies Tops Fund

Marshall Wace Investment Strategiesgtops Fund

Marshall Wace Investment Strategies - Systematic Alpha Plus Fund

Marshall Wace Investment Strategies Market Neutral Tops Fund

Marshall Wace Investment Strategies Systematic Alpha Plus Fund

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
16 Oct 2025	Purchase	11.76 Cr	₹1,107	1.06 L	Block	0.01829	NSE
16 Oct 2025	Sell	11.76 Cr	₹1,107	1.06 L	Block	0.01829	NSE
25 Jan 2024	Purchase	172.20 Cr	₹1,160.10	14.84 L	Block	0.255565	BSE
25 Jan 2024	Purchase	12.35 Cr	₹1,160.10	1.06 L	Block	0.018333	BSE
25 Jan 2024	Purchase	6.22 Cr	₹1,160.10	53.64 K	Block	0.009236	NSE
25 Jan 2024	Purchase	5.21 Cr	₹1,160.10	44.92 K	Block	0.007734	NSE
25 Jan 2024	Purchase	3.20 Cr	₹1,160.10	27.57 K	Block	0.004747	BSE
25 Jan 2024	Purchase	1.85 Cr	₹1,160.10	15.95 K	Block	0.002746	BSE
25 Jan 2024	Purchase	94.36 L	₹1,160.10	8.13 K	Block	0.0014	NSE
25 Jan 2024	Purchase	10 L	₹1,160.10	862	Block	0.000148	NSE

Insider trading & SAST

Client name

Mrs. Kambam Spoorthi

Mr. M Sumanth Kumar Reddy

M/S P Suneela Rani

Mr.k Nithyananda Reddy

Mrs.p Suneela Rani

Mr.m Sumanth Kumar Reddy

Trident Chemphar Limited

Mrs. Kambam Spoorthi

Mr.m Sumanth Kumar Reddy

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Dec 2024	Promoter	Pledge	—	—	—	4 L	08 Jan 2014	Creation	30,77,500	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	5.95 L	10 Jan 2014	Release	2,98,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	7 L	13 Jan 2014	Creation	1,65,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	4.50 L	24 Jan 2014	Release	47,91,297	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	10 L	13 Feb 2014	Release	1,55,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	2.10 L	13 Feb 2014	Creation	5,08,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	30 L	14 Feb 2014	Release	26,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	16 L	21 Feb 2014	Creation	42,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	1.11 L	13 Feb 2014	Release	29,66,500	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	50 K	17 Feb 2014	Release	4,58,000	SAST	Reg31	—

Aurobindo Pharma Share Price

1716.00-5.50 (-0.32%)

+54.61% past 1 Year

Aurobindo Pharma is one of the leading vertically integrated formulations & API manufacturing companies in the world. It has a strong R&D focus and has a multi-product portfolio with manufacturing

Corporate Actions

Date

Type

Details

2025-08-08

Dividend

4.0

2024-02-20

Dividend

1.5

2023-11-20

Dividend

3.0

2023-02-17

Dividend

3.0

2022-06-06

Dividend

4.5

2022-02-18

Dividend

1.5

2021-11-17

Dividend

1.5

2021-08-27

Dividend

1.5

2021-02-22

Dividend

1.5

2020-11-23

Dividend

1.25

2020-08-21

Dividend

1.25

2020-02-17

Dividend

1.75

2019-11-21

Dividend

1.25

2019-02-15

Dividend

1.25

2018-11-20

Dividend

1.25

2018-02-20

Dividend

1.0

2017-11-21

Dividend

1.5

2017-06-08

Dividend

1.25

2016-11-24

Dividend

1.25

2016-06-09

Dividend

0.7

2016-02-18

Dividend

0.7

2015-11-19

Dividend

0.6

2015-08-21

Dividend

0.5

2015-07-20

Bonus

1:1

2015-06-08

Dividend

1.0

2015-02-16

Dividend

2.0

2014-08-13

Dividend

1.5

2014-06-11

Dividend

1.75

2013-11-19

Dividend

1.25

2013-07-30

Dividend

0.5

2013-02-18

Dividend

1.0

2012-07-30

Dividend

1.0

2011-07-20

Dividend

1.0

2011-02-10

Split

5:1

2010-11-11

Dividend

5.0

2010-09-13

Dividend

2.0

Company details

Registered office

Plot No. 2 Maitrivihar Ameerpet Hyderabad Telangana PIN: 500038 Tel No: 040-23736370 / 23747340 Fax No: 040-23741080 / 23746833 Email: [email protected] Internet: www.aurobindo.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Mangalam Ramasubramanian Kumar, Chairman

K Nityananda Reddy, Vice Chairman & Managing Director

M Madan Mohan Reddy, Whole Time Director

Santanu Mukherjee, Non Executive Independent Director

Girish Paman Vanvari, Non Executive Independent Director

Punita Kumar Sinha, Non Executive Independent Director

P Sarath Chandra Reddy, Non Independent & Non Executive Director

PV Ramprasad Reddy, Promoter & Non-Executive Director

Satakarni Makkapati, Non Independent & Non Executive Director

B Adi Reddy, Company Secretary & Compliance Officer

Details

Aurobindo Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Aurobindo Pharma Share Price

Aurobindo Pharma Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Aurobindo Pharma Share Price

Aurobindo Pharma Share Price

Oscillators

Moving averages

Aurobindo Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Aurobindo Pharma Share Price

Corporate Actions

Company details

Aurobindo Pharma Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Aurobindo Pharma Share Price

News

Aurobindo Pharma to host analyst and investor meet on September 24

Aurobindo Pharma subsidiary’s Unit-II US FDA inspection ends with procedural note

Aurobindo Pharma gets USFDA nod for Beclomethasone HFA inhalation aerosol

Aurobindo Pharma subsidiary clears US FDA inspection at Apitoria Unit-IV API facility

Aurobindo Pharma schedules analyst and investor meet on September 22 morning

Aurobindo Pharma sees rumors of promoter-linked block deal activity today

Aurobindo Pharma sees market buzz on possible promoter-related block deal

Aurobindo Pharma creates new wholly owned unit Avogent Lifesciences Private Limited

Aurobindo Pharma gains as Lannett launches generic Advair Diskus in US market

Aurobindo Pharma unit launches first generic inhalation product in US market

Aurobindo Pharma unit gets US FDA EIR, inspection closed with issues

Aurobindo Pharma to hold investor and analyst meet on September 1

Aurobindo Pharma subsidiary Lannett faces four US FDA compliance issues

Aurobindo Pharma subsidiary Auro Peptides completes recent US FDA facility inspection

Aurobindo Pharma unit receives US FDA warning letter on Eugia facility

Citi maintains sell on Aurobindo Pharma with Rs 1,260 target

Clsa Maintains Hold On Aurobindo Pharma With Rs 1,600 Target

Bernstein keeps Aurobindo Pharma at Market Perform after steady Q1 growth

Aurobindo Pharma Maintains Growth Guidance After Strong First Quarter Performance

Bofa Securities maintains Buy on Aurobindo Pharma, targets Rs 1,800

Aurobindo Pharma Ltd Share Price Today

Aurobindo Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator